ID30255A - Metoda untuk mencegah atau menunda revaskularisasi berdasarkan kateter - Google Patents

Metoda untuk mencegah atau menunda revaskularisasi berdasarkan kateter

Info

Publication number: ID30255A
Authority: ID; Indonesia
Prior art keywords: caterater; delaying; preventing; methods; revascularization
Prior art date: 1998-09-30

Application number

IDW20010902A

Other languages

English (en)

Inventor

Donald Michael Black

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-30

Filing date

1999-07-08

Publication date

2001-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22289955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30255(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-07-08 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-11-15 Publication of ID30255A publication Critical patent/ID30255A/id

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Surgical Instruments (AREA)
Media Introduction/Drainage Providing Device (AREA)

IDW20010902A 1998-09-30 1999-07-08 Metoda untuk mencegah atau menunda revaskularisasi berdasarkan kateter ID30255A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10245798P	1998-09-30	1998-09-30

Publications (1)

Publication Number	Publication Date
ID30255A true ID30255A (id)	2001-11-15

Family

ID=22289955

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010902A ID30255A (id)	1998-09-30	1999-07-08	Metoda untuk mencegah atau menunda revaskularisasi berdasarkan kateter

Country Status (34)

Country	Link
US (1)	US20080119561A1 (id)
EP (1)	EP1117392B1 (id)
JP (1)	JP2002525321A (id)
KR (1)	KR20010079955A (id)
CN (1)	CN1197565C (id)
AP (1)	AP1708A (id)
AT (1)	ATE260100T1 (id)
AU (1)	AU768474B2 (id)
BG (1)	BG105471A (id)
BR (1)	BR9914098A (id)
CA (1)	CA2343299C (id)
CZ (1)	CZ20011035A3 (id)
DE (1)	DE69915084T2 (id)
DK (1)	DK1117392T3 (id)
EA (1)	EA007427B1 (id)
EE (1)	EE200100199A (id)
ES (1)	ES2214872T3 (id)
HR (1)	HRP20010236A2 (id)
HU (1)	HUP0103648A3 (id)
ID (1)	ID30255A (id)
IL (2)	IL141953A0 (id)
IS (1)	IS5889A (id)
NO (1)	NO20011615L (id)
NZ (1)	NZ510500A (id)
OA (1)	OA11787A (id)
PL (1)	PL346980A1 (id)
PT (1)	PT1117392E (id)
SI (1)	SI1117392T1 (id)
SK (1)	SK4122001A3 (id)
TR (1)	TR200100901T2 (id)
UA (1)	UA73292C2 (id)
WO (1)	WO2000018395A1 (id)
YU (1)	YU23901A (id)
ZA (1)	ZA200102230B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1216038T3 (da)	1999-08-30	2005-12-27	Sanofi Aventis Deutschland	Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
WO2001078747A1 (de) *	2000-04-18	2001-10-25	Bayer Aktiengesellschaft	Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
KR20030023698A (ko) *	2000-07-14	2003-03-19	워너-램버트 캄파니	카르복시알킬에테르를 사용하여 섭식 장애를 치료하는 방법
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
HU230253B1 (hu)	2001-01-26	2015-11-30	Merck Sharp & Dohme Corp	Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1355644T3 (da)	2001-01-26	2006-10-23	Schering Corp	Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja)	2001-09-21	2005-02-10	シェーリング　コーポレイション	ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004043457A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja)	2003-03-07	2006-08-31	シェーリング　コーポレイション	置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
CA2517571C (en)	2003-03-07	2011-07-05	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja)	2003-03-07	2010-12-01	シェーリングコーポレイション	高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5157025A (en) *	1991-04-01	1992-10-20	E. R. Squibb & Sons, Inc.	Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
AU1095695A (en) *	1993-11-09	1995-05-29	Brigham And Women's Hospital	Hmg-coa reductase inhibitors in the normalization of vascular endothelial dysfunction
US5957916A (en) *	1994-05-25	1999-09-28	The Trustees Of Columbia University In The City Of New York	Myocardial revascularization through the endocardial surface using a laser
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5648387A (en) *	1995-03-24	1997-07-15	Warner-Lambert Company	Carboxyalkylethers, formulations, and treatment of vascular diseases
AU720853B2 (en) *	1995-11-02	2000-06-15	Warner-Lambert Company	Method and pharmaceutical composition for regulating lipid concentration
SE506272C2 (sv) *	1996-03-18	1997-11-24	Paul Edholm	Förfarande och anordning för att bestämma bildläge och bildvinkel i en röntgenbild
IL117702A0 (en) *	1996-03-28	1996-07-23	Tel Aviv Medical Center Resear	Drug for hyperlipoproteinemia
WO1998001100A2 (en) *	1996-07-09	1998-01-15	Merck & Co., Inc.	Method for treating homozygous familial hypercholesterolemia
US5861399A (en) *	1996-07-17	1999-01-19	Heart Care Partners	Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US6180660B1 (en) *	1997-08-26	2001-01-30	Merck & Co., Inc.	Cholesterol-lowering therapy
NZ503982A (en) *	1997-12-12	2002-03-28	Warner Lambert Co	Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

1999
- 1999-07-08 YU YU23901A patent/YU23901A/sh unknown
- 1999-07-08 WO PCT/US1999/015385 patent/WO2000018395A1/en not_active Ceased
- 1999-07-08 NZ NZ510500A patent/NZ510500A/xx unknown
- 1999-07-08 BR BR9914098-5A patent/BR9914098A/pt not_active Application Discontinuation
- 1999-07-08 CN CNB998116297A patent/CN1197565C/zh not_active Expired - Fee Related
- 1999-07-08 DE DE69915084T patent/DE69915084T2/de not_active Revoked
- 1999-07-08 HU HU0103648A patent/HUP0103648A3/hu unknown
- 1999-07-08 EP EP99933763A patent/EP1117392B1/en not_active Revoked
- 1999-07-08 SK SK412-2001A patent/SK4122001A3/sk unknown
- 1999-07-08 OA OA1200100080A patent/OA11787A/en unknown
- 1999-07-08 SI SI9930535T patent/SI1117392T1/xx unknown
- 1999-07-08 PT PT99933763T patent/PT1117392E/pt unknown
- 1999-07-08 JP JP2000571914A patent/JP2002525321A/ja active Pending
- 1999-07-08 PL PL99346980A patent/PL346980A1/xx not_active Application Discontinuation
- 1999-07-08 AT AT99933763T patent/ATE260100T1/de not_active IP Right Cessation
- 1999-07-08 AU AU49750/99A patent/AU768474B2/en not_active Ceased
- 1999-07-08 CA CA002343299A patent/CA2343299C/en not_active Expired - Fee Related
- 1999-07-08 EA EA200100370A patent/EA007427B1/ru not_active IP Right Cessation
- 1999-07-08 AP APAP/P/2001/002112A patent/AP1708A/en active
- 1999-07-08 ID IDW20010902A patent/ID30255A/id unknown
- 1999-07-08 TR TR2001/00901T patent/TR200100901T2/xx unknown
- 1999-07-08 IL IL14195399A patent/IL141953A0/xx active IP Right Grant
- 1999-07-08 HR HR20010236A patent/HRP20010236A2/hr not_active Application Discontinuation
- 1999-07-08 ES ES99933763T patent/ES2214872T3/es not_active Expired - Lifetime
- 1999-07-08 DK DK99933763T patent/DK1117392T3/da active
- 1999-07-08 EE EEP200100199A patent/EE200100199A/xx unknown
- 1999-07-08 KR KR1020017004021A patent/KR20010079955A/ko not_active Ceased
- 1999-07-08 CZ CZ20011035A patent/CZ20011035A3/cs unknown
- 1999-08-07 UA UA2001042933A patent/UA73292C2/uk unknown
2001
- 2001-03-12 IL IL141953A patent/IL141953A/en not_active IP Right Cessation
- 2001-03-14 IS IS5889A patent/IS5889A/is unknown
- 2001-03-16 ZA ZA200102230A patent/ZA200102230B/en unknown
- 2001-03-29 NO NO20011615A patent/NO20011615L/no not_active Application Discontinuation
- 2001-04-25 BG BG105471A patent/BG105471A/xx unknown
2007
- 2007-11-28 US US11/946,217 patent/US20080119561A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AP1708A (en)	2007-01-10
UA73292C2 (en)	2005-07-15
DK1117392T3 (da)	2004-06-14
AU768474B2 (en)	2003-12-11
ZA200102230B (en)	2002-06-18
US20080119561A1 (en)	2008-05-22
JP2002525321A (ja)	2002-08-13
EP1117392B1 (en)	2004-02-25
SI1117392T1 (en)	2004-06-30
ES2214872T3 (es)	2004-09-16
BG105471A (bg)	2001-12-31
EP1117392A1 (en)	2001-07-25
EA200100370A1 (ru)	2001-10-22
EE200100199A (et)	2002-06-17
CN1342072A (zh)	2002-03-27
HUP0103648A2 (hu)	2003-08-28
CZ20011035A3 (cs)	2001-10-17
AP2001002112A0 (en)	2001-06-30
IS5889A (is)	2001-03-14
SK4122001A3 (en)	2002-06-04
BR9914098A (pt)	2001-07-31
NO20011615D0 (no)	2001-03-29
CA2343299A1 (en)	2000-04-06
YU23901A (sh)	2003-07-07
IL141953A0 (en)	2002-03-10
TR200100901T2 (tr)	2001-08-21
IL141953A (en)	2006-07-05
KR20010079955A (ko)	2001-08-22
EA007427B1 (ru)	2006-10-27
CN1197565C (zh)	2005-04-20
NZ510500A (en)	2003-10-31
HK1042436A1 (en)	2002-08-16
HRP20010236A2 (en)	2002-04-30
ATE260100T1 (de)	2004-03-15
OA11787A (en)	2005-07-26
HUP0103648A3 (en)	2003-10-28
AU4975099A (en)	2000-04-17
DE69915084D1 (de)	2004-04-01
WO2000018395A1 (en)	2000-04-06
NO20011615L (no)	2001-04-24
PL346980A1 (en)	2002-03-11
DE69915084T2 (de)	2004-07-22
CA2343299C (en)	2008-04-01
PT1117392E (pt)	2004-07-30

Publication	Publication Date	Title
DE69938817D1 (de)	2008-07-10	Erstellungsverfahren
FI981491L (fi)	1999-12-30	Tukiaseman konfigurointimenetelmä
DE69916360D1 (de)	2004-05-19	Flügelprofil
TR199900531A3 (tr)	1999-10-21	Pirazolopirimidinler ve pirazolotriazinler.
DE69943006D1 (de)	2011-01-13	Kühlkörper
DE69908200D1 (de)	2003-07-03	Korkenzieher
ID30255A (id)	2001-11-15	Metoda untuk mencegah atau menunda revaskularisasi berdasarkan kateter
ATE252547T1 (de)	2003-11-15	Matrixmetalloproteinaseinhibitoren
ID28624A (id)	2001-06-21	Turunan 2-fenilpiran-4-on
DE69904933D1 (de)	2003-02-20	Verriegelungsvorrichtung
ID23196A (id)	2000-03-30	Gandaran untuk lampuflouresen
FR2777750B1 (fr)	2000-09-15	Assaisonnement
DE59900726D1 (de)	2002-02-28	Verriegelungsvorrichtung
DE69810450D1 (de)	2003-02-06	Verriegelungsvorrichtung
DE59906422D1 (de)	2003-09-04	Stellvorrichtung
DE69818799D1 (de)	2003-11-13	Verriegelungsvorrichtung
DE69930852D1 (de)	2006-05-24	Prenyltransferase-inhibitoren
DE69909568D1 (de)	2003-08-21	Verriegelungsvorrichtung
NO994785L (no)	2000-04-03	Kabellås
FI981207L (fi)	1999-11-30	Demodulaatiomenetelmä
ES1039438Y (es)	1999-07-01	Expositor-expendedor perfeccionado.
FI3582U1 (fi)	1998-09-17	Vääntölaite
SE9804251D0 (sv)	1998-12-08	Låskomponent
FI980851L (fi)	1999-10-18	Lukitusväline
ATA124998A (de)	2000-08-15	Verschlusseinrichtung